The “Reforma Trabalhista”, or labor reform, is currently a very widely talked about subject in Brazil. This act plans to change some terms of the CLT (labor law). Labor law in Brazil has never been updated ever since its creation in 1943.
Biocon India is an Indian biopharmaceutical company based in Bangalore, India. The Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar insulins, which are sold in India as branded formulations and in both bulk and formulation forms. Biocon has a fully functioning, local Brazilian branch with staff and operations on the ground, Emerging markets (including Brazil) contribute to about 40% of Biocon’s sales.